Log in
Create new account
home
boards
job center
pharmagather
advertise
contact us
Home
MS
News
Biogen: Now 42 Cases Of Brain Infection In Tysabri Patients
WSJ Online
Biogen
Elan
MS
PML
Tysabri
»
Login
or
register
to post comments
News
Teva’s MS Treatment Copaxone Chalks Up 25% Sales Gain
WSJ Online
Copaxone
MS
multiple sclerosis
Teva
»
Login
or
register
to post comments
News
Teva, Active extend pact on oral MS therapy
Marketwatch
Active Biotech
MS
multiple sclerosis
partnership
Teva
»
Login
or
register
to post comments
News
Acorda's MS Drug May Not Be the Windfall Investors Expect
Seeking Alpha
Acorda
AMPYRA
Biogen
MS
multiple sclerosis
»
Login
or
register
to post comments
News
FDA approves Biogen Idec multiple sclerosis treatment Ampyra
Bizjournals.com
AMPYRA
Biogen
FDA
MS
multiple sclerosis
»
Login
or
register
to post comments
News
Novartis, Merck KGaA Pills Bring ‘New Horizon’ for MS
Bloomberg
Merck KGaA
MS
multiple sclerosis
Novartis
»
Login
or
register
to post comments
News
Biogen Idec says Tysabri sales top $1 billion, new patients grow 30 percent
Yahoo/AP
Biogen
MS
multiple sclerosis
Tysabri
»
Login
or
register
to post comments
News
Can Novartis Win Race to Launch First Oral Drug for MS?
BNET Pharma
Merck KGaA
MS
multiple sclerosis
Novartis
»
Login
or
register
to post comments
News
Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching
BNET Pharma
Biogen
FDA
MS
multiple sclerosis
social media
Tysabri
»
Login
or
register
to post comments
News
Avanir shares jump on new Zenvia data
Fierce Biotech
Avanir
MS
multiple sclerosis
Zenvia
»
Login
or
register
to post comments
1
2
3
4
5
6
7
8
next ›
last »
news tags
Abbott
Amgen
AstraZeneca
Biogen
biotech
Bristol-Myers Squibb
buyouts
cancer
China
diabetes
drug stocks
drug trials
earnings
Elan
Eli Lilly
FDA
Genentech
generics
Genzyme
Gilead
GSK
H1N1
healthcare reform
JNJ
layoffs
Lilly
M&A
Merck
Novartis
partnerships
patents
Pfizer
Pharma CEOs
Roche
Sanofi-Aventis
Schering-Plough
swine flu
Teva
vaccines
Wyeth
more tags
Yahoo! Finance
Quote for ABT